| 2026-05-13 |
详情>>
内部人交易：
Watson Noel Bertram股份减少2000.00股
|
| 2026-05-07 |
详情>>
股本变动：
变动后总股本33489.86万股
|
| 2026-05-07 |
详情>>
业绩披露：
2026年三季报(累计)每股收益0.94美元,归母净利润3.13亿美元,同比去年增长1935.97%
|
| 2026-05-07 |
财报披露：
美东时间 2026-05-07 盘后发布财报
|
| 2026-02-05 |
详情>>
业绩披露：
2026年中报每股收益0.63美元,归母净利润2.10亿美元,同比去年增长1158.71%
|
| 2025-11-06 |
详情>>
业绩披露：
2026年一季报每股收益0.24美元,归母净利润8069.40万美元,同比去年增长180.52%
|
| 2025-10-24 |
股东大会：
将于2025-12-15召开股东大会
会议内容 ▼▲
- 1.To elect the three Class II nominees for director named in the accompanying proxy statement to hold office until the 2028 Annual Meeting and until their successors have been duly elected and qualified or until such director’s earlier death, resignation or removal.
2.To ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026.
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers.
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2025-08-28 |
详情>>
业绩披露：
2023年年报每股收益-3.34美元,归母净利润-9.85亿美元,同比去年增长-39.29%
|
| 2025-08-28 |
详情>>
业绩披露：
2025年年报每股收益0.16美元,归母净利润5218.60万美元,同比去年增长110.08%
|
| 2025-05-12 |
股东大会：
将于2025-06-25召开股东大会
会议内容 ▼▲
- 1.To approve the reincorporation of the Company from the State of Delaware to the State of Nevada by conversion.
2.To approve one or more adjournments of the Special Meeting, if necessary, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve Proposal No. 1.
3.To conduct any other business properly brought before the Special Meeting.
|
| 2025-05-09 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.05美元,归母净利润-1705.8万美元,同比去年增长96.39%
|
| 2025-02-06 |
详情>>
业绩披露：
2025年中报每股收益-0.06美元,归母净利润-1986.2万美元,同比去年增长94.14%
|
| 2025-02-06 |
详情>>
业绩披露：
2024年中报每股收益-1.11美元,归母净利润-3.39亿美元,同比去年增长40.97%
|
| 2024-11-07 |
详情>>
业绩披露：
2025年一季报每股收益-0.31美元,归母净利润-1亿美元,同比去年增长41.66%
|
| 2024-10-25 |
股东大会：
将于2024-12-09召开股东大会
会议内容 ▼▲
- 1.To elect the three Class I nominees for director named in the accompanying proxy statement to hold office until the 2027 Annual Meeting and until their successors have been duly elected and qualified or until such director’s earlier death, resignation or removal.
2.To ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2025.
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers.
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2024-08-28 |
详情>>
业绩披露：
2024年年报每股收益-1.67美元,归母净利润-5.18亿美元,同比去年增长47.45%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.53美元,归母净利润-4.73亿美元,同比去年增长39.36%
|
| 2023-10-20 |
股东大会：
将于2023-12-04召开股东大会
会议内容 ▼▲
- 1.To elect the three Class III nominees for director named in the accompanying proxy statement to hold office until the 2026 Annual Meeting and until their successors have been duly elected and qualified or until such director’s earlier death, resignation or removal.
2.To ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2024.
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers.
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2022-10-21 |
股东大会：
将于2022-12-05召开股东大会
会议内容 ▼▲
- 1.To elect the three Class II nominees for director named in the accompanying proxy statement to hold office until the 2025 Annual Meeting and until their successors have been duly elected and qualified or until such director’s earlier death, resignation or removal.
2.To ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2023.
3.To conduct any other business properly brought before the Annual Meeting.
|
| 2022-02-11 |
复牌提示：
2022-02-10 15:07:45 停牌，复牌日期 2022-02-10 15:12:45
|
| 2021-10-20 |
股东大会：
将于2021-12-03召开股东大会
会议内容 ▼▲
- 1.To elect the two Class I nominees for director named in the accompanying proxy statement to hold office until the 2024 Annual Meeting and until their successors have been duly elected and qualified or until such director’s earlier death, resignation or removal.
2.To ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2022.
3.To approve, on an advisory (non-binding) basis, the frequency of future advisory votes to approve the compensation of our named executive officers.
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|